Literature DB >> 23390131

Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd2).

Roman H Khonsari1, Atsushi Ohazama, Ramin Raouf, Maiko Kawasaki, Katsushige Kawasaki, Thantrira Porntaveetus, Sarah Ghafoor, Peter Hammond, Michael Suttie, Guillaume A Odri, Richard N Sandford, John N Wood, Paul T Sharpe.   

Abstract

Polycystin 2 (Pkd2), which belongs to the transient receptor potential family, plays a critical role in development. Pkd2 is mainly localized in the primary cilia, which also function as mechanoreceptors in many cells that influence multiple biological processes including Ca(2+) influx, chemical activity and signalling pathways. Mutations in many cilia proteins result in craniofacial abnormalities. Orofacial tissues constantly receive mechanical forces and are known to develop and grow through intricate signalling pathways. Here we investigate the role of Pkd2, whose role remains unclear in craniofacial development and growth. In order to determine the role of Pkd2 in craniofacial development, we located expression in craniofacial tissues and analysed mice with conditional deletion of Pkd2 in neural crest-derived cells, using Wnt1Cre mice. Pkd2 mutants showed many signs of mechanical trauma such as fractured molar roots, distorted incisors, alveolar bone loss and compressed temporomandibular joints, in addition to abnormal skull shapes. Significantly, mutants showed no indication of any of these phenotypes at embryonic stages when heads perceive no significant mechanical stress in utero. The results suggest that Pkd2 is likely to play a critical role in craniofacial growth as a mechanoreceptor. Pkd2 is also identified as one of the genes responsible for autosomal dominant polycystic kidney disease (ADPKD). Since facial anomalies have never been identified in ADPKD patients, we carried out three-dimensional photography of patient faces and analysed these using dense surface modelling. This analysis revealed specific characteristics of ADPKD patient faces, some of which correlated with those of the mutant mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23390131     DOI: 10.1093/hmg/ddt041

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

Review 1.  Physiological mechanisms and therapeutic potential of bone mechanosensing.

Authors:  Zhousheng Xiao; Leigh Darryl Quarles
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

2.  Primary cilia integrate hedgehog and Wnt signaling during tooth development.

Authors:  B Liu; S Chen; D Cheng; W Jing; J A Helms
Journal:  J Dent Res       Date:  2014-03-21       Impact factor: 6.116

Review 3.  The role of transient receptor potential polycystin channels in bone diseases.

Authors:  Maria A Katsianou; Foteini G Skondra; Antonios N Gargalionis; Christina Piperi; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

4.  Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis.

Authors:  Zhousheng Xiao; Jerome Baudry; Li Cao; Jinsong Huang; Hao Chen; Charles R Yates; Wei Li; Brittany Dong; Christopher M Waters; Jeremy C Smith; L Darryl Quarles
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

Review 5.  Signaling networks in joint development.

Authors:  Joanna E Salva; Amy E Merrill
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

Review 6.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

Review 7.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

8.  Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development.

Authors:  Kazuo Noda; Megumi Kitami; Kohei Kitami; Masaru Kaku; Yoshihiro Komatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-26       Impact factor: 11.205

Review 9.  A Genetic-Pathophysiological Framework for Craniosynostosis.

Authors:  Stephen R F Twigg; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2015-09-03       Impact factor: 11.025

10.  Mineral bone disease in autosomal dominant polycystic kidney disease.

Authors:  Berenice Gitomer; Renata Pereira; Isidro B Salusky; Jason W Stoneback; Tamara Isakova; Xuan Cai; Lorien S Dalrymple; Norma Ofsthun; Zhiying You; Harmut H Malluche; Franklin Maddux; Diana George; Vicente Torres; Arlene Chapman; Theodore I Steinman; Myles Wolf; Michel Chonchol
Journal:  Kidney Int       Date:  2020-09-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.